EC Number | Application | Comment | Organism |
---|---|---|---|
2.4.1.132 | pharmacology | target for antifungal drug discovery | Cryptococcus neoformans |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.132 | GDP | - |
Cryptococcus neoformans | |
2.4.1.132 | mannose-1-phosphate | - |
Cryptococcus neoformans | |
2.4.1.132 | additional information | not inhibited by amphomycin or tunicamycin | Cryptococcus neoformans |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.1.132 | membrane | - |
Cryptococcus neoformans | 16020 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.132 | additional information | Cryptococcus neoformans | role in the synthesis of the glucuronoxylomannan of the capsule | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.132 | Cryptococcus neoformans | - |
pathogenic fungus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.132 | additional information | role in the synthesis of the glucuronoxylomannan of the capsule | Cryptococcus neoformans | ? | - |
? |